Ixigo’s board has approved the unaudited financial results for Q3 2026 and the nine months ending December 31, 2025. Additionally, 492,119 equity shares were allotted under various employee stock option schemes, increasing the company’s paid-up share capital from ₹437,579,188 to ₹438,071,307. The trading window will reopen for designated persons on January 25, 2026.
Financial Results Approved
The board of directors approved the unaudited financial results (consolidated and standalone) for Q3 2026 and the nine months ended December 31, 2025. Limited review reports were issued accordingly. These results are available as Annexure A.
Equity Shares Allotment
A total of 492,119 fully paid-up equity shares (face value of ₹1 each) were allotted. These shares were issued upon the exercise of stock options by option holders across several employee stock option schemes (ESOS):
- ESOS 2012
- ESOS 2013
- ESOS 2016
- ESOS 2020
- ESOS 2021
- ESOS 2024
As a result of this allotment, the company’s paid-up share capital increased from ₹437,579,188 to ₹438,071,307.
Additional Information
Details regarding the allotment, as per regulations, are available in Annexure B and Annexure C. The trading window will reopen for designated individuals on January 25, 2026. Further information can be found on the company website. The board meeting concluded at 4:04 PM (IST) on January 22, 2026.
Source: BSE
